Hypofractionated Image-Guided Radiation Therapy (IGRT) for patients with Stage II-III Non-Small Cell Lung Cancer
The study is designed to determine whether an accelerated course of hypofractionated radiation therapy with daily image guidance and motion assessment/control will allow more effective treatment of poor performance status patients with stage II-III non-small cell lung cancer (NSCLC), who would benefit from local therapy compared to standard radiation therapy (60 Gy in 2 Gy per fraction).
The primary objective is to compare one type of radiation therapy with another type in order to determine if one is better than the other.
The study will enroll approximately 226 patients from 5 cancer centers in Texas.
In addition to other conditions for enrollment, eligible patients have state II or III NSCLC and are otherwise in good health.
Patients who have a history of radiotherapy to the area that overlaps the area to be treated may not be eligible to enroll.
To enroll or if you have questions about participation